Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

ChromoGenics AB (publ): ChromoGenics triples its quotation stock

Read the release

During the past year, ChromoGenics has changed and expanded the sales organization and also broadened and improved the customer offering. This is behind ChromoGenic's great growth in quotation volume; from SEK 120 million in January to SEK 331 million in June.

The time period from quote to order is between 6 months and 2 years depending on the nature of the project. It is a shorter cycle on refurbishment projects compared to new constructions. ChromoGenic's quotation stock contains a good mix between these two types of projects.

So far, over 80% of the offers have led to an order and ChromoGenic's hope is that this will continue to be the case.

"It is very gratifying that our sales efforts provide such a good result. However, in order to cope with growth, we need to secure capacity and security in the deliveries. Already at today's volumes we are strained in the capacity and have had to go up to two shifts. It is therefore very valuable that we carry out the acquisition of sputtering machines as previously announced. Purchasing these state-of-the-art machines gives us the necessary capacity within 6 months compared to 18 to 24 months if we would have ordered new machines. It was an opportunity that appeared, which we are very grateful for", says ChromoGenics CEO Jerker Lundgren.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.